Medical News

RSS

When Social Security benefits are improved, older people benefit most

New findings from researchers at New York Medical College suggest that when Social Security benefits are improved, people over the age of 65 benefit most, and may even live longer.

18 Feb 2011

New study: Asthma may have relationship with airway microbiota composition

Asthma may have a surprising relationship with the composition of the species of bacteria that inhabit bronchial airways, a finding that could suggest new treatment or even potential cures for the common inflammatory disease, according to a new UCSF-led study.

18 Feb 2011

Research: Urban children spend more time playing outdoors

Young children living in urban public housing spend more time playing outdoors than other urban children, according to researchers at Rice University, Columbia University and Princeton University.

18 Feb 2011

Avenir team discovers how Neisseria meningitidis disseminates into bloodstream

Although, in the majority of cases, the localized presence of Neisseria meningitidis in the throat has no consequence, it can sometimes lead to meningitis or septicaemia. The seriousness of these two infections is driving researchers from around the world to improve their understanding of the mode of operation of this bacterium, which, once it leaves its favourite location becomes extremely dangerous.

18 Feb 2011

Massachusetts Gov. to unveil plan to curb health costs via payment reforms

Gov. Deval Patrick's legislation is designed to reduce health care costs by paying doctors and hospitals in lump sums for overall patient care rather than on a procedure-by-procedure basis. In addition, bonuses would be linked to patient outcomes.

18 Feb 2011

Sleeping Trojan horse technique resolves some difficulties in transporting metal ions into cells

A unique strategy developed by researchers at Cardiff University is opening up new possibilities for improving medical imaging.

18 Feb 2011

World's first cancer stem cell-targeting chemical missile

Deakin University medical scientists have created the world's first cancer stem cell-targeting chemical missile, placing them a step closer to creating a medical 'smart bomb' that would seek out and eradicate the root of cancer cells.

18 Feb 2011

Two studies investigate frontiers of islet cell transplantation for treating diabetes

Two studies published in the current issue of Cell Transplantation investigate frontiers of islet cell transplantation for treating diabetes. Researchers in Milan, Italy re-examine the role of bone marrow stem cells in diabetic therapy and islet cell regeneration and Canadian researchers offer improved strategies for optimizing pancreatic islet culture in vitro.

18 Feb 2011

Loyola offers stem cell transplants to older patients with leukemia and lymphoma

As the first baby boomers turn 65, Loyola University Hospital has begun offering stem cell transplants to leukemia and lymphoma patients who previously were too old to qualify.

18 Feb 2011

San Francisco area patient files DePuy hip replacement recall lawsuit

Wendy R. Fleishman, a partner in the national plaintiffs' law firm Lieff Cabraser Heimann & Bernstein, LLP, announces that Alec MacPhail, of Danville, California, has filed a personal injury lawsuit against DePuy Orthopedics, Inc., and its parent company, Johnson & Johnson, Inc., for manufacturing an allegedly defective prosthetic hip implant device sold under the brand name DePuy ASR XL Acetabular System.

18 Feb 2011

Entellus Medical enters license agreement with Acclarent to resolve patent lawsuit

Entellus Medical today announced that it has entered into a licensing agreement with Acclarent, Inc. in order to resolve their patent lawsuit. The license agreement is royalty bearing to Acclarent.

18 Feb 2011

ACS to provide therapy related assessment and training services to UCP

Ancillary Care Solutions, the nationwide leader in helping healthcare organizations establish and manage physical and occupational therapy programs, today announced it was chosen to provide therapy related assessment and training services to United Cerebral Palsy of Central Arizona, a non-profit health and human service organization that has served children and adults with disabilities since 1952.

18 Feb 2011

Intrinsic initiates enrollment in Barricaid device clinical trial

Intrinsic Therapeutics, Inc., a developer of novel lumbar spine anulus closure devices, announced today that it has enrolled the first patient, December 17, 2010, in a Randomized Clinical Trial of its Barricaid device.

18 Feb 2011

Opinions: U.S. foreign aid; Lay health workers

"The international affairs budget does more than just keep our nation safe - it bolsters our economy by creating jobs here and developing markets for U.S. goods and services overseas. It makes sense: effective development brings stability, economic development and a demand for goods and services," according to a Politico opinion piece by Reps. Gerald Connolly (D-Va.) and Leonard Lance (R-N.J.).

18 Feb 2011

Signs of P.A.D. indicate increased risk of heart disease, heart attack, death

Approximately nine million Americans over the age of 50 are living with a disease that affects their legs and raises their risk of having a heart attack. Unfortunately, many with the disease do not even know they have it. February is Heart Month, and the Vascular Disease Foundation and its P.A.D. Coalition are urging Americans to listen to their legs and be alert to the signs of peripheral arterial disease, or P.A.D.

18 Feb 2011

Research shows possible link between warm weather and cognition in people with MS

People with multiple sclerosis may find it harder to learn, remember or process information on warmer days of the year, according to new research released today that will be presented at the American Academy of Neurology's 63rd Annual Meeting in Honolulu April 9 to April 16, 2011.

18 Feb 2011

U.S. FDA approves Corifact to prevent bleeding in people with Factor XIII deficiency

The U.S. Food and Drug Administration today approved Corifact, the first product intended to prevent bleeding in people with the rare genetic defect congenital Factor XIII deficiency.

18 Feb 2011

FDA grants miRagen's MGN-4893 orphan drug designation for treatment of polycythemia vera

miRagen Therapeutics, Inc., a privately-held biopharmaceutical company focused on improving patients' lives by developing innovative microRNA (miRNA)-based therapeutics for cardiovascular and muscle disease, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the company's compound MGN-4893 for the treatment of polycythemia vera, a myeloproliferative disease characterized by an overabundance of blood cells and platelets in the body.

18 Feb 2011

Conatus commences multi-center CTS-1027 Phase 2b trial for HCV treatment

Conatus Pharmaceuticals Inc. announced today the treatment of the first patient in a multi-center Phase 2b clinical trial evaluating CTS-1027 in combination with Peginterferon Alfa-2a and ribavirin in a treatment experienced, hepatitis C null responder patient population. Safety, tolerability, and antiviral activity of the triple combination will be assessed after up to 48 weeks of therapy.

18 Feb 2011

Senate 'Gang of Six' develops deficit reduction framework

A bipartisan group of senators is considering legislation that would trigger new taxes and budget cuts if Congress fails to meet a set of mandatory spending targets and other fiscal goals aimed at reducing federal deficits. The plan would break the task of deficit reduction into four pieces: a tax code overhaul; discretionary spending cuts; changes to Medicare, Medicaid and other entitlements; and changes to Social Security, aides said.

17 Feb 2011

Medical News

When Social Security benefits are improved, older people benefit most

New study: Asthma may have relationship with airway microbiota composition

Research: Urban children spend more time playing outdoors

Avenir team discovers how Neisseria meningitidis disseminates into bloodstream

Massachusetts Gov. to unveil plan to curb health costs via payment reforms

Sleeping Trojan horse technique resolves some difficulties in transporting metal ions into cells

World's first cancer stem cell-targeting chemical missile

Two studies investigate frontiers of islet cell transplantation for treating diabetes

Loyola offers stem cell transplants to older patients with leukemia and lymphoma

San Francisco area patient files DePuy hip replacement recall lawsuit

Entellus Medical enters license agreement with Acclarent to resolve patent lawsuit

ACS to provide therapy related assessment and training services to UCP

Intrinsic initiates enrollment in Barricaid device clinical trial

Opinions: U.S. foreign aid; Lay health workers

Signs of P.A.D. indicate increased risk of heart disease, heart attack, death

Research shows possible link between warm weather and cognition in people with MS

U.S. FDA approves Corifact to prevent bleeding in people with Factor XIII deficiency

FDA grants miRagen's MGN-4893 orphan drug designation for treatment of polycythemia vera

Conatus commences multi-center CTS-1027 Phase 2b trial for HCV treatment

Senate 'Gang of Six' develops deficit reduction framework

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News